Publications in collaboration with researchers from Kenyatta National Hospital (2)

2022

  1. Rivaroxaban in Rheumatic Heart Disease–Associated Atrial Fibrillation

    New England Journal of Medicine, Vol. 387, Núm. 11, pp. 978-988

2020

  1. The INVICTUS rheumatic heart disease research program: Rationale, design and baseline characteristics of a randomized trial of rivaroxaban compared to vitamin K antagonists in rheumatic valvular disease and atrial fibrillation

    American Heart Journal, Vol. 225, pp. 69-77